NorthCrest Asset Manangement’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,700	Closed	-$87.6K	–	583
2024 Q3	$87.6K	Hold	11,700	–	–	﹤0.01%	545
2024 Q2	$104K	Hold	11,700	–	–	﹤0.01%	508
2024 Q1	$119K	Sell	11,700 -200	-2%	-$2.04K	﹤0.01%	496
2023 Q4	$120K	Hold	11,900	–	–	﹤0.01%	504
2023 Q3	$112K	Hold	11,900	–	–	﹤0.01%	492
2023 Q2	$292K	Sell	11,900 -400	-3%	-$10K	0.01%	447
2023 Q1	$286K	Buy	12,300 +900	+8%	+$23K	0.01%	445
2022 Q4	$289K	Buy	11,400 +800	+8%	+$19.6K	0.02%	357
2022 Q3	$204K	Hold	10,600	–	–	0.01%	419
2022 Q2	$270K	Hold	10,600	–	–	0.01%	388
2022 Q1	$273K	Buy	10,600 +200	+2%	+$5.93K	0.01%	369
2021 Q4	$435K	Buy	+10,400	New	+$407K	0.02%	327